The purpose of this research study is to see how metformin, when used in combination with standard of care (SOC) treatment for metastatic (cancer that has spre…

Sarcoma MetastaticSarcoma, Soft Tissue

~Estimated

~$10 – $6,250

Wake Forest University Health SciencesNCT07291297

Phase 2

A Non-Randomized, Open-label Phase II Trial Testing the Activity of XL092 (Zanzalintinib) in Patients With Advanced Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma

This phase II trial tests how well zanzalintinib (XL092) works in treating patients with leiomyosarcoma that has spread from where it first started to other pl…

Metastatic LeiomyosarcomaUnresectable LeiomyosarcomaBone Sarcoma+7 more

~Estimated

~$10 – $6,250

Northwestern UniversityNCT06571734